Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis - Concepedia

Concepedia

Publication | Closed Access

Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis

91

Citations

28

References

2014

Year

Niklas Bergvall, Allison Petrilla, Swapna Karkare, Raquel Lahoz, Neetu Agashivala, Ashish Pradhan, Gorana Capkun, Charles Makin, Catherine B. McGuiness, Jonathan R. Korn

Journal of Medical Economics

Abstract

In a real-world setting, persistence with, and adherence to, oral fingolimod was higher than for injectable and infusible DMTs.

References

	Year	Citations

Page 1